Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

News Daily News

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Todd Neale

November 20, 2018

News Conference News TCT 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

L.A. McKeown

September 27, 2018

News Conference News TCT 2018

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

Yael L. Maxwell

September 23, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

News Daily News

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

Michael O'Riordan

September 12, 2018

News Conference News ESC 2018

TAVR Debris Captured by Sentinel Embolic Protection Differs by Valve Type

Yael L. Maxwell

September 06, 2018

News Daily News

Concerning Rise in Younger Patients Getting TAVR, Despite Dearth of Data

L.A. McKeown

July 31, 2018

News Conference News The Structural Heart Disease Summit 2018

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

Michael O'Riordan

June 26, 2018

News Conference News The Structural Heart Disease Summit 2018

PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial

Shelley Wood

June 23, 2018

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

Presentation EuroPCR 2018

Real World Outcomes of TAVR with the SAPIEN-3 Valve in Intermediate Risk Patients: Comparison of Data from the TVT Registry with PARTNER S3 Studies

Presenter: E. Murat Tuzcu

May 25, 2018

News Conference News EuroPCR 2018

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

Caitlin E. Cox

May 25, 2018

News Conference News SCAI 2018

3-D Printing May Help TAVR Operators Avoid Paravalvular Leak

L.A. McKeown

April 26, 2018

News Daily News

Valve-in-Valve TAVR: Mortality, Adverse Events Similar to Redo Surgery at 30 Days

Yael L. Maxwell

April 25, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2018

Shelley Wood

April 02, 2018

News Daily News

Coronary Procedures After TAVR: New Practical Guide Reviews Tools, Techniques

Yael L. Maxwell

March 23, 2018

News Industry News

Edwards Completes Enrollment In PARTNER 3 Low-Risk CT Sub-Study, Updates Timeline For SAPIEN 3 Ultra System Launch In Europe

March 22, 2018

News Conference News CRT 2018

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

Shelley Wood

March 05, 2018

News Conference News CRT 2018

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Michael O'Riordan

March 05, 2018

Advertisement

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

High Mortality but Durable Results With Valve-in-Valve TAVR

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

TAVR Debris Captured by Sentinel Embolic Protection Differs by Valve Type

Concerning Rise in Younger Patients Getting TAVR, Despite Dearth of Data

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Real World Outcomes of TAVR with the SAPIEN-3 Valve in Intermediate Risk Patients: Comparison of Data from the TVT Registry with PARTNER S3 Studies

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

3-D Printing May Help TAVR Operators Avoid Paravalvular Leak

Valve-in-Valve TAVR: Mortality, Adverse Events Similar to Redo Surgery at 30 Days

TCTMD’s Top 10 Most Popular Stories for March 2018

Coronary Procedures After TAVR: New Practical Guide Reviews Tools, Techniques

Edwards Completes Enrollment In PARTNER 3 Low-Risk CT Sub-Study, Updates Timeline For SAPIEN 3 Ultra System Launch In Europe

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content